@ARTICLE{
author={Nabors Louis Burt,...,Grujicic Danica M,...,(broj koautora 17)},
year={2015},
title={Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study},
journal={NEURO-ONCOLOGY},
volume={17},
number={5},
pages={708-717},
document_type={Article},
} 

@ARTICLE{
author={Nabors Louis Burt,Fink Karen L,Mikkelsen Tom,Grujicic Danica M,Tarnawski Rafal,Nam Do-Hyun,Mazurkiewicz Maria,Salacz Michael,Ashby Lynn,Thurzo Laszlo,Zagonel Vittorina,Depenni Roberta,Perry James R,Henslee-Downey Jean,Picard Martin,Reardon David A},
year={2013},
title={Cilengitide in Combination with Standard Treatment for Patients with Newly Diagnosed Glioblastoma with Unmethylated O-6-Methylguanine- Dna Methyltransferase (Mgmt) Gene Promoter: Key Results of the Open-Label, Controlled, Randomized Phase Ii Core Study},
journal={NEURO-ONCOLOGY},
volume={15},
number={},
pages={80-80},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Nabors Louis Burt,Fink Karen L,Mikkelsen Tom,Grujicic Danica M,Tarnawski Rafal,Nam Do-Hyun,Perry James R,Mazurkiewicz Maria,Picard Martin,Reardon David A},
year={2013},
title={A randomized phase II study investigating cilengitide added to standard chemoradiotherapy in patients with newly diagnosed glioblastoma with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Initial report of the CORE study},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={},
pages={S17-S18},
document_type={Meeting Abstract},
}